The respiratory microbiome associated with chronic obstructive pulmonary disease comorbidity in non‐small cell lung cancer
Abstract Background Research has shown that some microbiomes are linked to cancer. Hence, we hypothesize that alterations in the respiratory microbiome might be associated with lung cancer. Methods Through droplet digital polymerase chain reaction analysis, we investigated the abundance of Acidovora...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-07-01
|
Series: | Thoracic Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1111/1759-7714.14463 |
_version_ | 1828335542405693440 |
---|---|
author | Masamitsu Shimizu Akihiko Miyanaga Masahiro Seike Kuniko Matsuda Masaru Matsumoto Rintaro Noro Kazue Fujita Yoko Mano Nobuhiko Furuya Kaoru Kubota Akihiko Gemma |
author_facet | Masamitsu Shimizu Akihiko Miyanaga Masahiro Seike Kuniko Matsuda Masaru Matsumoto Rintaro Noro Kazue Fujita Yoko Mano Nobuhiko Furuya Kaoru Kubota Akihiko Gemma |
author_sort | Masamitsu Shimizu |
collection | DOAJ |
description | Abstract Background Research has shown that some microbiomes are linked to cancer. Hence, we hypothesize that alterations in the respiratory microbiome might be associated with lung cancer. Methods Through droplet digital polymerase chain reaction analysis, we investigated the abundance of Acidovorax in surgically resected primary tumors and corresponding nontumor lung tissues obtained from 50 Japanese patients with non‐small cell lung cancer. Results The rate of positivity for Acidovorax in tumor and nontumor tissues was 44 and 26%, respectively. The abundance of Acidovorax in tumor tissues was significantly higher in patients with nonsquamous cell carcinoma complicated by chronic obstructive pulmonary disease (COPD) and those who relapsed after surgical resection (p < 0.05). In tumor tissues, the results of the univariate and multivariate analyses revealed that only COPD exerted a direct effect on the abundance of Acidovorax (p < 0.05). Furthermore, the presence of Acidovorax was high in lung cancer patients with COPD comorbidity (65%) and TP53 gene mutation; only one of the nontumor tissues was positive for Acidovorax. In patients with lung cancer complicated by COPD, Acidovorax tended to be present in both the tumor and nontumor areas. Conclusions This study identified novel microbiota involved in lung cancer with COPD comorbidity. The results suggested that Acidovorax may be a useful biomarker in the screening for lung cancer. Further studies are warranted to validate the clinical significance of the microbiome in a larger independent patient cohort. |
first_indexed | 2024-04-13T21:48:40Z |
format | Article |
id | doaj.art-0ab633eded5342b0b12ea89922f120f8 |
institution | Directory Open Access Journal |
issn | 1759-7706 1759-7714 |
language | English |
last_indexed | 2024-04-13T21:48:40Z |
publishDate | 2022-07-01 |
publisher | Wiley |
record_format | Article |
series | Thoracic Cancer |
spelling | doaj.art-0ab633eded5342b0b12ea89922f120f82022-12-22T02:28:29ZengWileyThoracic Cancer1759-77061759-77142022-07-0113131940194710.1111/1759-7714.14463The respiratory microbiome associated with chronic obstructive pulmonary disease comorbidity in non‐small cell lung cancerMasamitsu Shimizu0Akihiko Miyanaga1Masahiro Seike2Kuniko Matsuda3Masaru Matsumoto4Rintaro Noro5Kazue Fujita6Yoko Mano7Nobuhiko Furuya8Kaoru Kubota9Akihiko Gemma10Department of Pulmonary Medicine and Oncology, Graduate School of Medicine Nippon Medical School Tokyo JapanDepartment of Pulmonary Medicine and Oncology, Graduate School of Medicine Nippon Medical School Tokyo JapanDepartment of Pulmonary Medicine and Oncology, Graduate School of Medicine Nippon Medical School Tokyo JapanDepartment of Pulmonary Medicine and Oncology, Graduate School of Medicine Nippon Medical School Tokyo JapanDepartment of Pulmonary Medicine and Oncology, Graduate School of Medicine Nippon Medical School Tokyo JapanDepartment of Pulmonary Medicine and Oncology, Graduate School of Medicine Nippon Medical School Tokyo JapanDepartment of Pulmonary Medicine and Oncology, Graduate School of Medicine Nippon Medical School Tokyo JapanDepartment of Clinical Laboratory Medicine, Faculty of Health Science Technology Bunkyo Gakuin University Tokyo JapanDepartment of Clinical Laboratory Medicine, Faculty of Health Science Technology Bunkyo Gakuin University Tokyo JapanDepartment of Pulmonary Medicine and Oncology, Graduate School of Medicine Nippon Medical School Tokyo JapanDepartment of Pulmonary Medicine and Oncology, Graduate School of Medicine Nippon Medical School Tokyo JapanAbstract Background Research has shown that some microbiomes are linked to cancer. Hence, we hypothesize that alterations in the respiratory microbiome might be associated with lung cancer. Methods Through droplet digital polymerase chain reaction analysis, we investigated the abundance of Acidovorax in surgically resected primary tumors and corresponding nontumor lung tissues obtained from 50 Japanese patients with non‐small cell lung cancer. Results The rate of positivity for Acidovorax in tumor and nontumor tissues was 44 and 26%, respectively. The abundance of Acidovorax in tumor tissues was significantly higher in patients with nonsquamous cell carcinoma complicated by chronic obstructive pulmonary disease (COPD) and those who relapsed after surgical resection (p < 0.05). In tumor tissues, the results of the univariate and multivariate analyses revealed that only COPD exerted a direct effect on the abundance of Acidovorax (p < 0.05). Furthermore, the presence of Acidovorax was high in lung cancer patients with COPD comorbidity (65%) and TP53 gene mutation; only one of the nontumor tissues was positive for Acidovorax. In patients with lung cancer complicated by COPD, Acidovorax tended to be present in both the tumor and nontumor areas. Conclusions This study identified novel microbiota involved in lung cancer with COPD comorbidity. The results suggested that Acidovorax may be a useful biomarker in the screening for lung cancer. Further studies are warranted to validate the clinical significance of the microbiome in a larger independent patient cohort.https://doi.org/10.1111/1759-7714.14463COPDddPCRlung cancermicrobiome |
spellingShingle | Masamitsu Shimizu Akihiko Miyanaga Masahiro Seike Kuniko Matsuda Masaru Matsumoto Rintaro Noro Kazue Fujita Yoko Mano Nobuhiko Furuya Kaoru Kubota Akihiko Gemma The respiratory microbiome associated with chronic obstructive pulmonary disease comorbidity in non‐small cell lung cancer Thoracic Cancer COPD ddPCR lung cancer microbiome |
title | The respiratory microbiome associated with chronic obstructive pulmonary disease comorbidity in non‐small cell lung cancer |
title_full | The respiratory microbiome associated with chronic obstructive pulmonary disease comorbidity in non‐small cell lung cancer |
title_fullStr | The respiratory microbiome associated with chronic obstructive pulmonary disease comorbidity in non‐small cell lung cancer |
title_full_unstemmed | The respiratory microbiome associated with chronic obstructive pulmonary disease comorbidity in non‐small cell lung cancer |
title_short | The respiratory microbiome associated with chronic obstructive pulmonary disease comorbidity in non‐small cell lung cancer |
title_sort | respiratory microbiome associated with chronic obstructive pulmonary disease comorbidity in non small cell lung cancer |
topic | COPD ddPCR lung cancer microbiome |
url | https://doi.org/10.1111/1759-7714.14463 |
work_keys_str_mv | AT masamitsushimizu therespiratorymicrobiomeassociatedwithchronicobstructivepulmonarydiseasecomorbidityinnonsmallcelllungcancer AT akihikomiyanaga therespiratorymicrobiomeassociatedwithchronicobstructivepulmonarydiseasecomorbidityinnonsmallcelllungcancer AT masahiroseike therespiratorymicrobiomeassociatedwithchronicobstructivepulmonarydiseasecomorbidityinnonsmallcelllungcancer AT kunikomatsuda therespiratorymicrobiomeassociatedwithchronicobstructivepulmonarydiseasecomorbidityinnonsmallcelllungcancer AT masarumatsumoto therespiratorymicrobiomeassociatedwithchronicobstructivepulmonarydiseasecomorbidityinnonsmallcelllungcancer AT rintaronoro therespiratorymicrobiomeassociatedwithchronicobstructivepulmonarydiseasecomorbidityinnonsmallcelllungcancer AT kazuefujita therespiratorymicrobiomeassociatedwithchronicobstructivepulmonarydiseasecomorbidityinnonsmallcelllungcancer AT yokomano therespiratorymicrobiomeassociatedwithchronicobstructivepulmonarydiseasecomorbidityinnonsmallcelllungcancer AT nobuhikofuruya therespiratorymicrobiomeassociatedwithchronicobstructivepulmonarydiseasecomorbidityinnonsmallcelllungcancer AT kaorukubota therespiratorymicrobiomeassociatedwithchronicobstructivepulmonarydiseasecomorbidityinnonsmallcelllungcancer AT akihikogemma therespiratorymicrobiomeassociatedwithchronicobstructivepulmonarydiseasecomorbidityinnonsmallcelllungcancer AT masamitsushimizu respiratorymicrobiomeassociatedwithchronicobstructivepulmonarydiseasecomorbidityinnonsmallcelllungcancer AT akihikomiyanaga respiratorymicrobiomeassociatedwithchronicobstructivepulmonarydiseasecomorbidityinnonsmallcelllungcancer AT masahiroseike respiratorymicrobiomeassociatedwithchronicobstructivepulmonarydiseasecomorbidityinnonsmallcelllungcancer AT kunikomatsuda respiratorymicrobiomeassociatedwithchronicobstructivepulmonarydiseasecomorbidityinnonsmallcelllungcancer AT masarumatsumoto respiratorymicrobiomeassociatedwithchronicobstructivepulmonarydiseasecomorbidityinnonsmallcelllungcancer AT rintaronoro respiratorymicrobiomeassociatedwithchronicobstructivepulmonarydiseasecomorbidityinnonsmallcelllungcancer AT kazuefujita respiratorymicrobiomeassociatedwithchronicobstructivepulmonarydiseasecomorbidityinnonsmallcelllungcancer AT yokomano respiratorymicrobiomeassociatedwithchronicobstructivepulmonarydiseasecomorbidityinnonsmallcelllungcancer AT nobuhikofuruya respiratorymicrobiomeassociatedwithchronicobstructivepulmonarydiseasecomorbidityinnonsmallcelllungcancer AT kaorukubota respiratorymicrobiomeassociatedwithchronicobstructivepulmonarydiseasecomorbidityinnonsmallcelllungcancer AT akihikogemma respiratorymicrobiomeassociatedwithchronicobstructivepulmonarydiseasecomorbidityinnonsmallcelllungcancer |